Development of cellular immune responses to Plasmodium falciparum blood stage antigens from birth to 36 months of age in Cameroon
- PMID: 16820138
- DOI: 10.1016/j.actatropica.2006.05.010
Development of cellular immune responses to Plasmodium falciparum blood stage antigens from birth to 36 months of age in Cameroon
Abstract
Naturally acquired immunity to Plasmodium falciparum is related to immune system that changes during normal development and ageing. The effects of repeated infections during the early life on the maturation of the immune system are still unknown. Elucidation of these effects is of considerable interest given that malaria originates high mortality, especially during the first years of life. We conducted a cohort study to identify naturally acquired immune responses to P. falciparum. Cellular responses of Cameroonian neonates from birth to 36 months of age were evaluated every 6 months by cell proliferation and cytokines (IFN-gamma, IL-2 and IL-4) production after in vitro culture in the presence of schizont extract and Pf155/RESA peptides. Data were analyzed by a multiple correspondence analysis (MCA) exhibiting three main findings. Firstly, the lack of time-dependant evolution of specific immune pathways recruitment in the response to a given antigen, no antigen inducing a specific mode of response at a given time-point. Secondly, most of the data variability was expressed by IFN-gamma and IL-4 productions, and the major variation of the immune response with age involved this change in IFN-gamma production. Thirdly, the age-related immune response evolution is characterized by the acquisition of the capacity to mount a IFN-gamma response, a transient phase during which children produce a high IL-4 response, and the fast vanishing of the dominance of the IL-2 response. These results suggest that P. falciparum specific immune responses are first oriented towards a Th2-type of response, and later switch to Th1-type of response.
Similar articles
-
Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.Eur Cytokine Netw. 2001 Oct-Dec;12(4):647-53. Eur Cytokine Netw. 2001. PMID: 11781192
-
Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.Scand J Infect Dis Suppl. 1996;102:1-53. Scand J Infect Dis Suppl. 1996. PMID: 9060051 Review.
-
Studies on Plasmodium falciparum isotypic antibodies and numbers of IL-4 and IFN-gamma secreting cells in paired maternal cord blood from South West Cameroon.Int J Infect Dis. 2005 May;9(3):159-69. doi: 10.1016/j.ijid.2004.06.012. Int J Infect Dis. 2005. PMID: 15840457
-
Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children.Clin Infect Dis. 2008 Dec 1;47(11):1380-7. doi: 10.1086/592971. Clin Infect Dis. 2008. PMID: 18947328
-
Placental Plasmodium falciparum infection: causes and consequences of in utero sensitization to parasite antigens.Mol Biochem Parasitol. 2007 Jan;151(1):1-8. doi: 10.1016/j.molbiopara.2006.10.001. Epub 2006 Oct 19. Mol Biochem Parasitol. 2007. PMID: 17081634 Review.
Cited by
-
A Balanced Proinflammatory and Regulatory Cytokine Signature in Young African Children Is Associated With Lower Risk of Clinical Malaria.Clin Infect Dis. 2019 Aug 16;69(5):820-828. doi: 10.1093/cid/ciy934. Clin Infect Dis. 2019. PMID: 30380038 Free PMC article. Clinical Trial.
-
Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.PLoS Med. 2016 Feb 23;13(2):e1001964. doi: 10.1371/journal.pmed.1001964. eCollection 2016 Feb. PLoS Med. 2016. PMID: 26905278 Free PMC article. Clinical Trial.
-
Mefloquine safety and tolerability in pregnancy: a systematic literature review.Malar J. 2014 Feb 28;13:75. doi: 10.1186/1475-2875-13-75. Malar J. 2014. PMID: 24581338 Free PMC article.
-
Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.BMC Immunol. 2012 Jan 26;13:5. doi: 10.1186/1471-2172-13-5. BMC Immunol. 2012. PMID: 22280502 Free PMC article. Clinical Trial.
-
Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.Malar J. 2009 Jul 16;8:162. doi: 10.1186/1475-2875-8-162. Malar J. 2009. PMID: 19607717 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical